<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kho S</submitter><funding>Bill &amp; Melinda Gates Foundation</funding><pagination>7286</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9068623</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(1)</volume><pubmed_abstract>Commercial point-of-care tests remain insufficient for accurately detecting and differentiating low-level malaria infections in regions co-endemic with multiple non-falciparum species, including zoonotic Plasmodium knowlesi (Pk). A 5-plex chemiluminescent assay simultaneously measures pan-Plasmodium lactate dehydrogenase (pLDH), P. falciparum (Pf)-LDH, P. vivax (Pv)-LDH, Pf-histidine-rich protein-2 (HRP2), and C-reactive protein. We assessed its diagnostic performance on whole blood (WB) samples from 102 healthy controls and 306 PCR-confirmed clinical cases of Pf, Pv, Pk, P. malariae (Pm) and P. ovale (Po) mono-infections from Southeast-Asia. We confirm its excellent HRP2-based detection of Pf. Cross-reactivity of Pf-LDH with all non-falciparum species tested was observed (specificity 57.3</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Diagnostic performance of a 5-plex malaria immunoassay in regions co-endemic for Plasmodium falciparum, P. vivax, P. knowlesi, P. malariae and P. ovale.</pubmed_title><pmcid>PMC9068623</pmcid><funding_grant_id>INV1135840</funding_grant_id><pubmed_authors>Jang IK</pubmed_authors><pubmed_authors>Kenangalem E</pubmed_authors><pubmed_authors>Kho S</pubmed_authors><pubmed_authors>Domingo GJ</pubmed_authors><pubmed_authors>Piera K</pubmed_authors><pubmed_authors>McCarthy JS</pubmed_authors><pubmed_authors>William T</pubmed_authors><pubmed_authors>Anstey NM</pubmed_authors><pubmed_authors>Britton S</pubmed_authors><pubmed_authors>Barber BE</pubmed_authors><pubmed_authors>Grigg MJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Diagnostic performance of a 5-plex malaria immunoassay in regions co-endemic for Plasmodium falciparum, P. vivax, P. knowlesi, P. malariae and P. ovale.</name><description>Commercial point-of-care tests remain insufficient for accurately detecting and differentiating low-level malaria infections in regions co-endemic with multiple non-falciparum species, including zoonotic Plasmodium knowlesi (Pk). A 5-plex chemiluminescent assay simultaneously measures pan-Plasmodium lactate dehydrogenase (pLDH), P. falciparum (Pf)-LDH, P. vivax (Pv)-LDH, Pf-histidine-rich protein-2 (HRP2), and C-reactive protein. We assessed its diagnostic performance on whole blood (WB) samples from 102 healthy controls and 306 PCR-confirmed clinical cases of Pf, Pv, Pk, P. malariae (Pm) and P. ovale (Po) mono-infections from Southeast-Asia. We confirm its excellent HRP2-based detection of Pf. Cross-reactivity of Pf-LDH with all non-falciparum species tested was observed (specificity 57.3</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-18T15:43:54.787Z</modification><creation>2025-02-19T04:21:47.253Z</creation></dates><accession>S-EPMC9068623</accession><cross_references><pubmed>35508558</pubmed><doi>10.1038/s41598-022-11042-w</doi></cross_references></HashMap>